Navigation Links
Collexis BiomedExperts Fast Approaching 150,000 Registered Users
Date:4/15/2009

BiomedExperts.com Established As the Gold Standard Supporting Collexis Expert Platforms for Translational Research

COLUMBIA, S.C., April 15 /PRNewswire-FirstCall/ -- Collexis Holdings, Inc. (OTC Bulletin Board: CLXS), a leading developer of semantic search and knowledge discovery software, announced today that their life science research portal www.BiomedExperts.com has blown past the 145,000 registered user mark and will easily surpass 150,000 by the end of April. The unique visitor traffic in March has exploded to over 60,000 per day and surpassed 1.8 million unique visitors in March!

(Logo: http://www.newscom.com/cgi-bin/prnh/20090107/CLW051LOGO )

"BiomedExperts continues to grow at a very rapid pace and we are highly confident we will go beyond 200,000 registered life science researchers by the fall," stated Bill Kirkland, CEO of Collexis. "Over the next six months we plan to add a number of key features, enhancements and partners to BiomedExperts. Currently, in beta, we are providing our members with weekly alerts of their publications in BiomedExperts as well as new publications within their network. Further this fall, we plan to launch the consumer version of BiomedExperts.com which will allow the global audience to access this life science portal from a healthcare perspective."

"Because the U.S. economic stimulus plan has a significant focus on scientific research, we feel that BiomedExperts will continue to grow as the research community will have an increasing need for effective tools to promote collaboration with other scientists," states Dr. Christian Herzog, M.D., Managing Director for Collexis STM markets. "BiomedExperts is the supporting
'/>"/>

SOURCE Collexis Holdings, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related biology technology :

1. Collexis Connects Biomedical Researchers and Clinical Scientists with the Collexis Expert Platform for Translational Research
2. Collexis Connects the NIH Clinical and Translational Science Award Programs with CTSA Expert Platform
3. American Association for Cancer Research (AACR) Deploys Collexis Reviewer Finder and Journal Dashboard Applications
4. BioFlorida Selects Collexis BiomedExperts.com as the Primary Professional Network for its 200 Member Companies and Organizations
5. Countering an approaching water crisis
6. Huntington Area Development Council Attracts Technology-Based Startup Companies With $150,000 Grant From Verizon West Virginia
7. The PLSG Invests $150,000 in Coventina Healthcare Enterprises, Inc., Its Eighth Company Relocation to Pittsburgh
8. Savient Pharmaceuticals to Raise $31 Million Through Registered Direct Offering
9. Pharmasset Announces $45.5 Million Registered Direct Offering of Common Stock
10. Immtech Announces Appointment of Virchow Krause as Independent Registered Public Accounting Firm
11. Catalyst Pharmaceutical Partners, Inc. Announces a $4.5 Million Registered Direct Common Stock Offering

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/24/2009)...AI,Nov.24/PRNewswire-Asia/--ShanghaiBiolaxyannounc...)hasapprovedthe,investigationalnewdrugapplication(...insulinformulationtotreatdiabetes.ThisIND,approval.... , Diabetesisadisordercharacteristicofhighbl...betesoftenresultinseveremicro-and,macro-vasculardi...
(Date:11/24/2009)... The FBI recently approved the Promega ...ticipating in or generating DNA records for the Na... Madison, WI USA (PRWEB) -- The FBI recently appr... use by laboratories participating in, or generati...(NDIS). NDIS currently contains more than seven mi...
(Date:11/24/2009)...TURE:HTL , TORONTO,Nov.24/PRNewswire-FirstCal...pitalInc.,aleadingproviderofadvancedlasersystemsan...icmarkets,todayreportedoperationalandfinancialresu...2009Highlights,-Revenuewas$1.46millioncomparedwit...centcomparedwith66.1percentinQ3,2008,-Netlossreduc...
(Date:11/24/2009)...GO,Nov.24,2009/PRNewswire-FirstCall/--ArenaPharmac...ecompanyisscheduledtopresentatthePiperJaffray21stA...m.EasternTime(8:30a.m.PacificTime)attheNewYorkPala...dChiefExecutiveOfficer,isscheduledtoprovideanoverv...discoveryprograms. ,, Aliveaudiowebcastofthepre...
Breaking Biology Technology:Biolaxy Secures IND Approval for Oral Insulin 2NDIS Approval of Promega PowerPlex Kit Clears Path for More DNA Profiles to be Added to U.S. Database 2Hamilton Thorne announces third quarter results 2Hamilton Thorne announces third quarter results 3Hamilton Thorne announces third quarter results 4Hamilton Thorne announces third quarter results 5Hamilton Thorne announces third quarter results 6Hamilton Thorne announces third quarter results 7Arena Pharmaceuticals to Present at the Piper Jaffray 21st Annual Health Care Conference 2
...O, Oct. 14 Nile Therapeutics,Inc. (Nasdaq: NLTX ...ter,open-label Phase 2a clinical study of CD-NP, a...ospitalized for acute heart failure., -- Statis...ry wedge pressure -- Statistically signific...on in right atrial pressure -- Trend toward incr...
...pport creation of market incentives and facilitate...O Ventures for Global,Health (BVGH) today announce...anded its support of the organization, so it can f... create new medicines for infectious,diseases of t...p BVGH build,the market case for biotechnology ind...
...ct. 14 Althea Technologies, Inc., a leading,provi...armaceutical,development and manufacturing, announ...fast growth awards, Deloitte LLP,s San Diego Techn...00 Fastest Growing Private Companies,for the fifth... is an,annual ranking of the 50 fastest growing te...
Other Biology Technology:Nile Therapeutics Announces Positive Interim Data from Phase 2a Study of CD-NP in Patients with Heart Failure 2Nile Therapeutics Announces Positive Interim Data from Phase 2a Study of CD-NP in Patients with Heart Failure 3Nile Therapeutics Announces Positive Interim Data from Phase 2a Study of CD-NP in Patients with Heart Failure 4Nile Therapeutics Announces Positive Interim Data from Phase 2a Study of CD-NP in Patients with Heart Failure 5BIO Ventures for Global Health Receives $7 Million Grant from Gates Foundation to Engage Biotechnology in the Fight Against Neglected Diseases of the Developing World 2Althea Technologies Receives Fast Growth Honors: Deloitte Technology Fast 50 and San Diego Business Journal Fast 100 Awards for the Fifth Consecutive Year 2
(Date:11/23/2009)...e of day matters to forest trees dealing with drou...ch team led by Professor Malcolm Campbell, Univers...search and colleagues in the department of cell an...Capitalizing on their previous work to decode the ...ned how poplar trees use their 45,000 genes to res...
(Date:11/23/2009)...ipants gathered this week for the seventh annual N...ce. This year,s topic, "Synthetic Biology," brough...archers to explore the engineering, scientific, an...synthetic biology. , Bonnie L. Bassler, professo... this year,s conference chair, challenged the atte...
(Date:11/23/2009)...s "incontrovertible evidence" that the volcanic su...t 73,000 years ago deforested much of central Indi...s report. , The volcano ejected an estimated 800...ing a crater (now the world,s largest volcanic lak...ide. Ash from the event has been found in India, t...
Breaking Biology News(10 mins):Time of day matters to thirsty trees, U of T researcher discovers 2Synthetic biology offers new opportunities for interdisciplinary collaboration 2Supervolcano eruption -- in Sumatra -- deforested India 73,000 years ago 2Bausch 26 Lomb Vision Care Strengthens Its Commitment to ReNu 28R 29 Brand and the Eye Care Community 50159 1Bausch 26 Lomb Vision Care Strengthens Its Commitment to ReNu 28R 29 Brand and the Eye Care Community 50159 2Bausch 26 Lomb Vision Care Strengthens Its Commitment to ReNu 28R 29 Brand and the Eye Care Community 50159 3Positive CHMP Opinion for JAVLOR 28R 29 in Metastatic Treatment of Bladder Cancer After Failure of a Prior Platinum Containing Regimen 50155 1Positive CHMP Opinion for JAVLOR 28R 29 in Metastatic Treatment of Bladder Cancer After Failure of a Prior Platinum Containing Regimen 50155 2Positive CHMP Opinion for JAVLOR 28R 29 in Metastatic Treatment of Bladder Cancer After Failure of a Prior Platinum Containing Regimen 50155 3RainEarth Obtains Patent Approvals for Its Core Technology 50153 1RainEarth Obtains Patent Approvals for Its Core Technology 50153 2RainEarth Obtains Patent Approvals for Its Core Technology 50153 3
...ornia,s Viterbi School of Engineering have success...onic Transmission Tomography" (HUTT) system that o...o those produced by existing commercial X-ray, ult...essor of biomedical engineering at the Viterbi Sch...in San Diego at the 28th International Acoustical ...
...iversity of Melbourne, Australia, has conducted th...volution of one of nature,s most sophisticated bio...the March issue of the journal Genome Research. , ...amily Colubroidea, evolved glands for the storage ...million years ago. Since that time, various prey-i...
...tes stem from bat bites, far more people are treat...e list of most often reported rabid mammal. Contro...he spatial dynamics of the disease - where new out... In a new study reported in the freely-available o...ply a mathematical model to predict the likely spr...
Other Biology News:A probe, not an echo 2A probe, not an echo 3A probe, not an echo 4Venom doc tracks down snake bioweapons 2Rabies spread speeds up 2
Goat Anti-Human ROR1 Polyclonal Antibody, Unconjugated from R&D Systems
Mouse Anti-Human Rad1 Monoclonal Antibody, Unconjugated, Clone 33 from R&D Systems
Sheep Growth Hormone from Cell Sciences
Rat Anti-Mouse Semaphorin 6B Monoclonal Antibody, Unconjugated, Clone 256537 from R&D Systems
Biology Products: